Cargando…

Coordinated changes of HIV-1 Gag and Env during assembly and maturation

Detalles Bibliográficos
Autor principal:	Kräusslich, Hans-Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848298/ http://dx.doi.org/10.1186/1742-4690-10-S1-O2

Ejemplares similares

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Gag-Pol Processing during HIV-1 Virion Maturation: A Systems Biology Approach
por: Könnyű, Balázs, et al.
Publicado: (2013)

Induction of HIV-specific T-cell responses by gag
por: Van Gulck, Ellen, et al.
Publicado: (2006)

Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding
por: Sette, Paola, et al.
Publicado: (2013)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
por: Ondondo, Beatrice, et al.
Publicado: (2006)

Synchronized HIV assembly by tunable PIP(2) changes reveals PIP(2) requirement for stable Gag anchoring
por: Mücksch, Frauke, et al.
Publicado: (2017)

OA05-05. Impact of in vivo CD4 binding during HIV-1 Env trimer immunizations of rhesus macaques
por: Douagi, I, et al.
Publicado: (2009)

High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation
por: Mattei, Simone, et al.
Publicado: (2018)

N-terminal foamy virus Gag domains and individual residues are critical for capsid assembly and interaction with the unique Env leader protein Elp for Env-dependent budding
por: Liu, Yang, et al.
Publicado: (2013)

Infiltration of dendritic cells and antigen uptake in the muscle after injection of HIV-1 Env gp120 in adjuvant
por: Liang, F, et al.
Publicado: (2012)

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
por: Wheatley, AK, et al.
Publicado: (2009)

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
por: Pejawar-Gaddy, S, et al.
Publicado: (2012)

Endogenous retrovirus type W GAG and ENV antigenaemia in serum of schizophrenic patients
por: Bernard, Corinne, et al.
Publicado: (2009)

Shaping humoral responses against mini-libraries of HIV env antigens via lipid nanoparticle vaccine delivery
por: Hanson, MC, et al.
Publicado: (2012)

P04-32. Differential regulation of secondary antibody responses to Gag and Env proteins
por: Nabi, G, et al.
Publicado: (2009)

Endocytic Motif on a Biotin-Tagged HIV-1 Env Modulates the Co-Transfer of Env and Gag during Cell-to-Cell Transmission
por: Barría, María Inés, et al.
Publicado: (2021)

The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation
por: Murphy, R. Elliot, et al.
Publicado: (2020)

In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers
por: Caskey, M, et al.
Publicado: (2012)

Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
por: Gatignol, A, et al.
Publicado: (2014)

Live-cell observation of cytosolic HIV-1 assembly onset reveals RNA-interacting Gag oligomers
por: Hendrix, Jelle, et al.
Publicado: (2015)

Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution in vivo
por: Pasternak, Alexander, et al.
Publicado: (2013)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Oral immunization with a recombinant Lactococcus lactis expressing HIV-1 Gag on the tip of the pilus induces strong mucosal immune responses
por: Chamcha, V, et al.
Publicado: (2012)

Effect of ART on poly functional profile of CD8 responses to Gag and Nef antigen in HIV infected Indian individuals
por: Mendiratta, Sanjay, et al.
Publicado: (2014)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
por: Wild, J, et al.
Publicado: (2009)

A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART
por: Jackson, AG, et al.
Publicado: (2012)

The role of murine leukemia virus glycosated Gag protein in virus replication
por: Fan, Hung
Publicado: (2011)

HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
por: Goffinet, Christine, et al.
Publicado: (2009)

S03-05 OA. A less differentiated memory phenotype of Gag-specific CD4+ T-cells during primary HIV infection associates with viral control at 12 months
por: Maenetje, PW, et al.
Publicado: (2009)

Re-visiting the functional Relevance of the highly conserved Serine 40 Residue within HIV-1 p6(Gag)
por: Radestock, Benjamin, et al.
Publicado: (2014)

Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging
por: Wang, Lili, et al.
Publicado: (2019)

Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner
por: Hahn, Friedrich, et al.
Publicado: (2017)

S04-06 OA. Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads
por: Julg, B, et al.
Publicado: (2009)

Hyperinsulinemia during in vitro oocyte maturation changes gene expression of insulin signaling in bovine Day-8 embryos
por: Laskowski, Denise, et al.
Publicado: (2015)

Cholesterol in the Viral Membrane is a Molecular Switch Governing HIV‐1 Env Clustering
por: Nieto‐Garai, Jon Ander, et al.
Publicado: (2020)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
por: Almond, N, et al.
Publicado: (2012)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
por: Debyser, Zeger
Publicado: (2013)

Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques
por: Valentin, Antonio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h2s64ovvvom7sv12quf5lddtc5